Corporate Profile interviews Micro Cap Investor, Joe Salvani on Implant Sciences (IMSC)
One Response to “Corporate Profile interviews Micro Cap Investor, Joe Salvani on Implant Sciences (IMSC)”
Leave a Reply
You must be logged in to post a comment.
FINANCIAL MODELS
FEATURES
CP REPORTS
CP Reports
- The Goldman Guide: Why The Market Hates Us… June 18, 2013 by Rob Goldman
- Market Alert: Wall Street Rumblings # CLIX June 17, 2013 by Ray Dirks
- Sam Seiden Market Commentary: The White Space… June 16, 2013 by Sam Seiden
- The Goldman Guide: The Future of Small Stock Investors…June 10, 2013 by Rob Goldman
- Market Alert: Wall Street Rumblings # CLVIII June 10, 2013 by Ray Dirks
- Sam Seiden Market Commentary: Is Trading Really An Art? June 4, 2013
admin
26. Jul, 2012
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences’ QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company’s QS-B220 desktop explosives and drugs trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company’s website at http://www.implantsciences.com.